期刊文献+

Crystal Structure of a Mn(Ⅱ) Coordination Polymer:[Mn(TP)(TBZH)_(2n)(TBZH=Thiabendazole,TP=Terephthalic Acid) 被引量:2

Crystal Structure of a Mn(Ⅱ) Coordination Polymer:[Mn(TP)(TBZH)_(2n)(TBZH=Thiabendazole,TP=Terephthalic Acid)
在线阅读 下载PDF
导出
摘要 The structure of a manganese(Ⅱ) polymer,[Mn(TP)(TBZH)]2n 1(TBZH=thiabendazole,TP=terephthalic acid),has been determined by X-ray crystallography and characterized by elemental analysis,IR spectrum and thermogravimetric analysis.It crystallizes in the orthorhombic system,space group Pbcn with a=12.7813(12),b=10.7544(10),c=20.1270(19)A,V=2766.6(4)A^3,Z=8,C14H9Mn0.50N3O2S,Mr=310.77,Dc=1.492g/cm^3,F(000)=1268,μ=0.674 mm^-1 and S=1.064.The 1-D chain architecture of 1 is constructed from terephthalic acid and manganese atoms.Hydrogen bonds and aryl ring π-π stacking interactions in 1 contribute to form a 3-D supramo-lecular structure. The structure of a manganese(Ⅱ) polymer,[Mn(TP)(TBZH)]2n 1(TBZH=thiabendazole,TP=terephthalic acid),has been determined by X-ray crystallography and characterized by elemental analysis,IR spectrum and thermogravimetric analysis.It crystallizes in the orthorhombic system,space group Pbcn with a=12.7813(12),b=10.7544(10),c=20.1270(19)A,V=2766.6(4)A^3,Z=8,C14H9Mn0.50N3O2S,Mr=310.77,Dc=1.492g/cm^3,F(000)=1268,μ=0.674 mm^-1 and S=1.064.The 1-D chain architecture of 1 is constructed from terephthalic acid and manganese atoms.Hydrogen bonds and aryl ring π-π stacking interactions in 1 contribute to form a 3-D supramo-lecular structure.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2010年第2期240-244,共5页 结构化学(英文)
基金 supported by Siping Sci-tech Development Planning Project (No 2005012)
关键词 THIABENDAZOLE manganese(Ⅱ) complex single-crystal structure thiabendazole,manganese(Ⅱ) complex,single-crystal structure
  • 相关文献

参考文献24

  • 1Blake, A. J.; Champncss, N. R.; Hubbcrstcy, P.; Li, W. S.; Withcrsby, M. A.; Schrodcr, M. Coord. Chem. Rev. 1999, 183, 117-138.
  • 2Hagrman, E J.; Hagrman, D.; Zubieta, J. Angew. Chem., Int. Ed. 1999, 38, 2638-2803.
  • 3Braun, P. V.; Osenar, P.; Tohver, V,; Kennedy, S. B.; Stupp, S. I. J. Am. Chem. Soc. 1999, 121, 7302-7309.
  • 4Chen, W.; Yuan, H. M.; Wang, J. Y.; Liu, Z. Y.; Xu, J. J.; Yang, M.; Chen, J. S..L Am. Chem. Soc. 2003, 125, 9266-9277.
  • 5Maji, T. K.; Mostafa, G.; Matsuda, R.; Kitagawa, S.J. Am. Chem. Soc. 2005, 127, 17152-17153.
  • 6Mahata, P.; Natarajan, S. Inorg. Chem. 2007, 46, 1250-1258.
  • 7Devereux, M.; McCann, M.; Shea, D. O.; Kelly, R; Egan, D.; Deegan, C.; McKee, V..L. Inorg. Biochem. 2004, 98, 1023-1031.
  • 8Kaniskan N.; Ogrctir, C. J. Mol. Struct. 2002, 584, 45-52.
  • 9Devereux, M.; Shea, D. 0.; KelleR, A.; McCann, M.; Walsh, M.; Egan, D.; Deegan, C.; Kedziora, K.; Rosair, G.; Muller-Bunz, H. J. Inorg. Biochem. 2007, 101,881--892.
  • 10Higashi, T. Program for Absorption Correction. Rigaku Corporation, Tokyo, Japan 1995.

同被引文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部